Compare Etsy Inc (ETSY) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Inovio Pharmaceuticals Inc — how do they compare? Etsy Inc trades at $76.71 (market cap $6.90B), while Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M). The key difference: Etsy Inc is far larger — about 61.5× Inovio Pharmaceuticals Inc's market cap, and Etsy Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| ETSY | INO | |
|---|---|---|
Market Cap | $6.90B | $112.19M |
Volume | 2,923,867 | 3,201,278 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $2.60 |
52-Week Low | $44.05 | $0.66 |
Typical Hold Time | 67 Days | 43 Days |
Enterprise Value | $8.85B | $83.51M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $75.14, up 5.11% today, reflecting strong momentum. The stock shows a bullish technical outlook with consistent earnings beats and a 53.33% analyst buy rating. Recent news highlights AI integration to enhance personalization and renewed payment partnerships, supporting growth. Revenue reached $2.88B in 2025, though net income margin dipped to 5.65%. Cash flow improved with $593.18M net inflow in 2025, but high debt and negative equity pose financial risks.
The outlook is cautiously optimistic with a consensus price target of $85.94 offering ~14% upside. Strengths include robust gross margins and strategic AI initiatives, but risks involve elevated valuation multiples, competitive pressures, and sensitivity to consumer spending trends. Investors should weigh growth potential against balance sheet concerns.
INO trades at $1.09, down 5.63% today, with a bearish technical outlook and negative financial metrics including a net income margin of -130,000% and ROE of -409.87%. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, though recent earnings have beaten expectations. Key near-term catalyst is the FDA decision on INO-3107 by October 30, 2026.
Despite analyst consensus favoring Buy ratings (58.83%) with a $2.75 price target, INO carries high risk due to persistent cash burn, negative profitability, and dependency on regulatory approvals. The stock offers speculative upside if INO-3107 gains approval but remains vulnerable to further dilution and operational setbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
